Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Open Label Study of Hydroxychloroquine for Alopecia Areata, Alopecia Totalis
Brief Summary: Alopecia areata is an autoimmune condition resulting in hair loss and complete baldness (alopecia totalis). Published evidence says that it is mediated by T-lymphocytes. Plaquenil is an anti-inflammatory drug approved by the FDA for malaria, lupus erythematosus, and rheumatoid arthritis. It has an effect on T-lymphocyte mediated inflammation, making it a logical choice for a treatment trail for alopecia areata.